Xiamen Amoytop Biotech: Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.

SZSI · Aug 22

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.